205 related articles for article (PubMed ID: 35527334)
1. Precise Metabolomics Reveals a Diversity of Aging-Associated Metabolic Features.
Tian H; Ni Z; Lam SM; Jiang W; Li F; Du J; Wang Y; Shui G
Small Methods; 2022 Jul; 6(7):e2200130. PubMed ID: 35527334
[TBL] [Abstract][Full Text] [Related]
2. The combination of four analytical methods to explore skeletal muscle metabolomics: Better coverage of metabolic pathways or a marketing argument?
Bruno C; Patin F; Bocca C; Nadal-Desbarats L; Bonnier F; Reynier P; Emond P; Vourc'h P; Joseph-Delafont K; Corcia P; Andres CR; Blasco H
J Pharm Biomed Anal; 2018 Jan; 148():273-279. PubMed ID: 29059617
[TBL] [Abstract][Full Text] [Related]
3. Next-generation metabolic screening: targeted and untargeted metabolomics for the diagnosis of inborn errors of metabolism in individual patients.
Coene KLM; Kluijtmans LAJ; van der Heeft E; Engelke UFH; de Boer S; Hoegen B; Kwast HJT; van de Vorst M; Huigen MCDG; Keularts IMLW; Schreuder MF; van Karnebeek CDM; Wortmann SB; de Vries MC; Janssen MCH; Gilissen C; Engel J; Wevers RA
J Inherit Metab Dis; 2018 May; 41(3):337-353. PubMed ID: 29453510
[TBL] [Abstract][Full Text] [Related]
4. Differential 12C-/13C-isotope dansylation labeling and fast liquid chromatography/mass spectrometry for absolute and relative quantification of the metabolome.
Guo K; Li L
Anal Chem; 2009 May; 81(10):3919-32. PubMed ID: 19309105
[TBL] [Abstract][Full Text] [Related]
5. Serum global metabolomics profiling reveals profound metabolic impairments in patients with MPS IIIA and MPS IIIB.
Fu H; Meadows AS; Pineda RJ; Mohney RP; Stirdivant S; McCarty DM
Metab Brain Dis; 2017 Oct; 32(5):1403-1415. PubMed ID: 28382573
[TBL] [Abstract][Full Text] [Related]
6. An integrated deep learning framework for the interpretation of untargeted metabolomics data.
Tian L; Yu T
Brief Bioinform; 2023 Jul; 24(4):. PubMed ID: 37369636
[TBL] [Abstract][Full Text] [Related]
7. Challenges and emergent solutions for LC-MS/MS based untargeted metabolomics in diseases.
Cui L; Lu H; Lee YH
Mass Spectrom Rev; 2018 Nov; 37(6):772-792. PubMed ID: 29486047
[TBL] [Abstract][Full Text] [Related]
8. Methods used to increase the comprehensive coverage of urinary and plasma metabolomes by MS.
Chen Y; Xu J; Zhang R; Abliz Z
Bioanalysis; 2016 May; 8(9):981-97. PubMed ID: 27079429
[TBL] [Abstract][Full Text] [Related]
9. Widely targeted metabolomic analysis reveals the dynamic changes of metabolites during postmortem chilled aging in Mongolian sheep.
Zhang M; Sun L; Su R; Corazzin M; Yang Z; Dou L; Hu G; Zhang Y; Liu T; Guo Y; Zhao L; Su L; Tian J; Jin Y
Food Chem; 2024 Jan; 431():137035. PubMed ID: 37567080
[TBL] [Abstract][Full Text] [Related]
10. Metabolome changes are induced in the arbuscular mycorrhizal fungus Gigaspora margarita by germination and by its bacterial endosymbiont.
Dearth SP; Castro HF; Venice F; Tague ED; Novero M; Bonfante P; Campagna SR
Mycorrhiza; 2018 Aug; 28(5-6):421-433. PubMed ID: 29860608
[TBL] [Abstract][Full Text] [Related]
11. Global mass spectrometry based metabolomics profiling of erythrocytes infected with Plasmodium falciparum.
Sana TR; Gordon DB; Fischer SM; Tichy SE; Kitagawa N; Lai C; Gosnell WL; Chang SP
PLoS One; 2013; 8(4):e60840. PubMed ID: 23593322
[TBL] [Abstract][Full Text] [Related]
12. DnsID in MyCompoundID for rapid identification of dansylated amine- and phenol-containing metabolites in LC-MS-based metabolomics.
Huan T; Wu Y; Tang C; Lin G; Li L
Anal Chem; 2015 Oct; 87(19):9838-45. PubMed ID: 26327437
[TBL] [Abstract][Full Text] [Related]
13. Chemical Isotope Labeling LC-MS for High Coverage and Quantitative Profiling of the Hydroxyl Submetabolome in Metabolomics.
Zhao S; Luo X; Li L
Anal Chem; 2016 Nov; 88(21):10617-10623. PubMed ID: 27690392
[TBL] [Abstract][Full Text] [Related]
14. Metabolomics-guided global pathway analysis reveals better insights into the metabolic alterations of breast cancer.
Long NP; Heo D; Kim HY; Kim TH; Shin JG; Lee A; Kim DH
J Pharm Biomed Anal; 2021 Aug; 202():114134. PubMed ID: 34052553
[TBL] [Abstract][Full Text] [Related]
15. Precision of a Clinical Metabolomics Profiling Platform for Use in the Identification of Inborn Errors of Metabolism.
Ford L; Kennedy AD; Goodman KD; Pappan KL; Evans AM; Miller LAD; Wulff JE; Wiggs BR; Lennon JJ; Elsea S; Toal DR
J Appl Lab Med; 2020 Mar; 5(2):342-356. PubMed ID: 32445384
[TBL] [Abstract][Full Text] [Related]
16. [Metabolome and mass spectrometry: new biomedical analysis perspectives].
Chao De La Barca JM; Mirebeau-Prunier D; Moal V; Reynier P; Garnotel R; Simard G
Ann Biol Clin (Paris); 2015; 73(1):126-30. PubMed ID: 25582729
[TBL] [Abstract][Full Text] [Related]
17. Application of metabolomics technologies toward cancer prognosis and therapy.
Hoang G; Udupa S; Le A
Int Rev Cell Mol Biol; 2019; 347():191-223. PubMed ID: 31451214
[TBL] [Abstract][Full Text] [Related]
18. PAIRUP-MS: Pathway analysis and imputation to relate unknowns in profiles from mass spectrometry-based metabolite data.
Hsu YH; Churchhouse C; Pers TH; Mercader JM; Metspalu A; Fischer K; Fortney K; Morgen EK; Gonzalez C; Gonzalez ME; Esko T; Hirschhorn JN
PLoS Comput Biol; 2019 Jan; 15(1):e1006734. PubMed ID: 30640898
[TBL] [Abstract][Full Text] [Related]
19. High resolution mass spectrometry based techniques at the crossroads of metabolic pathways.
Junot C; Fenaille F; Colsch B; Bécher F
Mass Spectrom Rev; 2014; 33(6):471-500. PubMed ID: 24288070
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
